| Authored | 2 |
| Substantive (25+ words) | 2 |
| Threads posted in | 2 |
| Distinct active days | 2 |
| Words authored | 663 |
| Received (incl. group broadcast) | 3 |
Received counts include every message sent to a channel this person belonged to. That measures presence, not participation.
8 sentences were extracted and attributed to this person. Most are not their own opinion. Reporting the total as “8 statements” would misrepresent them.
| Person | Medium | Msgs | Span |
|---|---|---|---|
| John Mascola | 3 | 2014-08-08 – 2014-08-08 | |
| Anthony S. Fauci | 2 | 2014-08-08 – 2022-08-02 | |
| Courtney Billet | 2 | 2017-04-19 – 2017-05-11 | |
| H. Clifford Lane | 1 | 2022-08-02 – 2022-08-02 |
Showing: own voice, substantive needs context quoted / not their view all
We have been getting a lot of additional clarifying questions from BARDA subsequent to our telecom, so I am fairly confident they will fund production of 1 "lot" of vaccine, but I remain unclear as to when we will hear definitively.
Gates Package, p.79 · original PDF · in context
We currently have adequate vaccine stock for our NIH-based phase 1, an expanded phase 1 in Uganda (100 subjects with MHRP), and 1 or 2 other African phase 1 trials.
Gates Package, p.79 · original PDF · in context
Whether the funding comes to us or GSK, we will both use a contract mechanism to have the vaccine produced at Advent, which is the Okairos facility that made the first lot for us under contract.
Gates Package, p.79 · original PDF · in context
I think the problem is that the FDA wants to say that they have a better vaccine coming.
Tony's Diary Package, p.1007 · original PDF · in context
Instead, they should be saying that if people need vaccination now they should get the vaccine now.
Tony's Diary Package, p.1007 · original PDF · in context
As with all vaccines, they will be rolling out updated vaccines as they become available and when there are data to support the change.
Tony's Diary Package, p.1007 · original PDF · in context
People in need of vaccines now should not delay in hopes of getting a "better" vaccine.
Tony's Diary Package, p.1007 · original PDF · in context
Koup, MD Acting Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH Tel: 301-594-8585 Fax: 301-480-2779 rkoup@mail.nih.gov Had my twice daily follow up conversation with Kevin O'Connor regarding the condition of the president.
Tony's Diary Package, p.1007 · original PDF · in context